首页> 美国卫生研究院文献>Cancer Science >Promotion of the Warburg effect is associated with poor benefit from adjuvant chemotherapy in colorectal cancer
【2h】

Promotion of the Warburg effect is associated with poor benefit from adjuvant chemotherapy in colorectal cancer

机译:改善Warburg效应与结直肠癌辅助化疗获益差有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Metabolic reprogramming, including the Warburg effect, is a hallmark of cancer. Indeed, the diversity of cancer metabolism leads to cancer heterogeneity, but accurate assessment of metabolic properties in tumors has not yet been undertaken. Here, we performed absolute quantification of the expression levels of 113 proteins related to carbohydrate metabolism and antioxidant pathways, in stage III colorectal cancer surgical specimens from 70 patients. The Warburg effect appeared in absolute protein levels between tumor and normal mucosa specimens demonstrated. Notably, the levels of proteins associated with the tricarboxylic citric acid cycle were remarkably reduced in the malignant tumors which had relapsed after surgery and treatment with 5‐fluorouracil‐based adjuvant therapy. In addition, the efficacy of 5‐fluorouracil also decreased in the cultured cancer cell lines with promotion of the Warburg effect. We further identified nine and eight important proteins, which are closely related to the Warburg effect, for relapse risk and 5‐fluorouracil benefit, respectively, using a biomarker exploration procedure. These results provide us a clue for bridging between metabolic protein expression profiles and benefit from 5‐fluorouracil adjuvant chemotherapy.
机译:包括Warburg效应在内的代谢重编程是癌症的标志。确实,癌症代谢的多样性导致癌症异质性,但是尚未进行肿瘤代谢特性的准确评估。在这里,我们对来自70例患者的III期大肠癌外科手术标本中与碳水化合物代谢和抗氧化途径相关的113种蛋白质的表达水平进行了绝对定量。 Warburg效应出现在肿瘤和正常黏膜标本之间的绝对蛋白质水平上。值得注意的是,在手术和基于5-氟尿嘧啶的辅助治疗后复发的恶性肿瘤中,与三羧酸柠檬酸循环相关的蛋白质水平显着降低。此外,5-氟尿嘧啶的功效在培养的癌细胞系中也随着Warburg效应的促进而降低。我们还使用生物标记物探索程序分别鉴定了9种和8种与Warburg效应密切相关的重要蛋白质,它们分别具有复发风险和5-氟尿嘧啶益处。这些结果为我们在代谢蛋白表达谱之间架起桥梁以及从5-氟尿嘧啶辅助化疗中获益提供了线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号